The medical test-making company Abbott has finalized its acquisition of Exact Sciences, the Madison-based maker of cancer screening and diagnostic tests, it said in a March 23 announcement. The deal, ...
Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segments Advances Abbott's mission to make healthcare more accessible and give people more control over their health ...
MADISON, Wis. -- Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as ...
Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. What day is the first day of spring 2026? Friday, March 20, ...
Crimson Desert is just a couple of days away from launching in the UK and across the rest of the world, going live on Thursday, March 19. The game will be made immediately available on PlayStation 5, ...
Joey Votto appeared on the Jim Day podcast earlier this week and told a fascinating story about the exact moment he knew his career as a baseball player was over. Day and Votto were talking about the ...
Exact Sciences Corporation EXAS reported a net loss of 21 cents per share in fourth-quarter 2025, higher than the year-ago loss of 6 cents. The figure matched the Zacks Consensus Estimate. Full-year ...
The first part of this series covered the growing sense of mistrust between buyers and their travel management agencies as a result of content gaps that have grown wider since New Distribution ...
Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...
Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results